Ionis says RNA drug for rare brain disorder succeeded pivotal trial, plans to ask for FDA approval

Ionis Pharmaceuticals said its experimental antisense oligonucleotide helped stabilize mobility in patients with a rare and often deadly neurological condition called Alexander disease. The Carlsbad, CA-based biotech now plans to ask ...